Julian Downward, Cancer biologist at the Francis Crick Institute, shared on X:
“In our new paper just out in Science Advances we investigate mechanisms that may be limiting responses of KRAS mutant lung cancer to KRAS inhibitors and immunotherapy.”
Authors: Megan Cole, Panayiotis Anastasiou, Claudia Lee, Xiaofei Yu, Andrea De Castro, Jannes Roelink, Chris Moore, Edurne Mugarza, Martin Jones, Karishma Valand, Sareena Rana, Emma Colliver, Mihaela Angelova, Katey S. S. Enfield, Alastair Magness, Asher Mullokandov, Gavin Kelly, Tanja D. De Gruijl, Miriam Molina-Arcas, Charles Swanton, Julian Downward, Febe Van Maldeghem.